Items where authors include "King, MT"

Article

Musoro, JZ, Coens, C, Sprangers, MAG et al. (18 more authors) (2023) Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types. European Journal of Cancer, 188. pp. 171-182. ISSN 0959-8049

Koller, M, Musoro, JZ, Tomaszewski, K et al. (8 more authors) (2022) Corrigendum to “Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trials” [Lung Cancer 167C (2022) 65–72]. Lung Cancer, 171. p. 126. ISSN 0169-5002

Koller, M, Musoro, JZ, Tomaszewski, K et al. (8 more authors) (2022) Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trials. Lung Cancer. ISSN 0169-5002

Gamper, EM, Musoro, JZ, Coens, C et al. (9 more authors) (2021) Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials. BMC cancer, 21 (1). 1083. ISSN 1471-2407

Dirven, L, Musoro, JZ, Coens, C et al. (13 more authors) (2021) Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients. Neuro-Oncology, 23 (8). pp. 1327-1336. ISSN 1522-8517

Retzer, A, Calvert, M, Ahmed, K et al. (15 more authors) (2021) International perspectives on suboptimal patient‐reported outcome trial design and reporting in cancer clinical trials: A qualitative study. Cancer Medicine, 10 (16). pp. 5475-5487. ISSN 2045-7634

King, MT, Norman, R, Mercieca-Bebber, R et al. (27 more authors) (2021) The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set. Value in Health, 24 (6). pp. 862-873. ISSN 1098-3015

Musoro, JZ, Sodergren, SC, Coens, C et al. (11 more authors) (2020) Minimally important differences for interpreting the EORTC QLQ‐C30 in advanced colorectal cancer patients treated with chemotherapy. Colorectal Disease, 22 (12). pp. 2278-2287. ISSN 1462-8910

Musoro, JZ, Coens, C, Greimel, E et al. (10 more authors) (2020) Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer. Gynecologic Oncology, 159 (2). pp. 515-521. ISSN 0090-8258

Musoro, JZ, Coens, C, Singer, S et al. (12 more authors) (2020) Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer. Head & Neck, 42 (11). pp. 3141-3152. ISSN 1043-3074

Kyte, D, Retzer, A, Ahmed, K et al. (16 more authors) (2019) Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials. JNCI: Journal of the National Cancer Institute, 111 (11). pp. 1170-1178. ISSN 0027-8874

Musoro, JZ, Coens, C, Frederic, F et al. (9 more authors) (2019) Minimally important differences for interpreting EORTC QLQ-C30 scores in patients with advanced breast cancer. JNCI: Journal of the National Cancer Institute, 3 (3). pkz037. ISSN 0027-8874

Musoro, JZ, Bottomley, A, Coens, C et al. (8 more authors) (2018) Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma. European Journal of Cancer, 104. pp. 169-181. ISSN 0959-8049

Petersen, MA, Aaronson, NK, Arraras, JI et al. (26 more authors) (2018) The EORTC CAT Core—The computer adaptive version of the EORTC QLQ-C30 questionnaire. European Journal of Cancer, 100. pp. 8-16. ISSN 0959-8049

Calvert, M, Kyte, D, Mercieca-Bebber, R et al. (4 more authors) (2018) Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension. JAMA - Journal of the American Medical Association, 319 (5). pp. 483-494. ISSN 0098-7484

Retzer, A, Keeley, T, Ahmed, K et al. (16 more authors) (2018) Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol. BMJ Open, 8 (2). e017282. ISSN 2044-6055

King, MT, Viney, R, Pickard, AS et al. (14 more authors) (2018) Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30. PharmacoEconomics, 36 (2). pp. 225-238. ISSN 1170-7690

Musoro, ZJ, Hamel, J-F, Ediebah, DE et al. (10 more authors) (2018) Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol. BMJ Open, 8 (1). e019117.

Ahmed, K, Kyte, D, Keeley, T et al. (15 more authors) (2016) Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocol. BMJ Open, 6 (9). e012863. ISSN 2044-6055

Zikos, E, Coens, C, Quinten, C et al. (16 more authors) (2016) The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative. Journal of the National Cancer Institute, 108 (5). ISSN 0027-8874

King, MT, Costa, DSJ, Aaronson, NK et al. (12 more authors) (2016) QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30. Quality of Life Research, 25 (3). pp. 625-636. ISSN 0962-9343

Norman, R, Viney, R, Aaronson, NK et al. (12 more authors) (2016) Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format. Quality of Life Research, 25 (3). pp. 637-649. ISSN 0962-9343

Kyte, D, Reeve, BB, Efficace, F et al. (9 more authors) (2016) International Society for Quality of Life Research commentary on the draft European Medicines Agency reflection paper on the use of patient-reported outcome (PRO) measures in oncology studies. Quality of Life Research, 25 (2). pp. 359-362. ISSN 0962-9343

Dong, ST, Costa, DS, Butow, PN et al. (10 more authors) (2016) Symptom Clusters in Advanced Cancer Patients: An Empirical Comparison of Statistical Methods and the Impact on Quality of Life. Journal of Pain and Symptom Management, 51 (1). pp. 88-98. ISSN 0885-3924

Quinten, C, Coens, C, Ghislain, I et al. (17 more authors) (2015) The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients. European journal of cancer, 51 (18). 2808 - 2819. ISSN 0959-8049

Proceedings Paper

Musoro, JZ, Coens, C, Sprangers, MAG et al. (14 more authors) (2022) Synthesis of anchor-based minimally important differences (MID) for the EORTC QLQ-C30 scales across nine cancer sites. In: Quality of Life Research. 29th Annual Conference of the International Society for Quality of Life Research, 19-22 Oct 2022, Prague, Czech Republic. Springer , S47-S48.

Kyte, D, Retzer, A, Ahmed, K et al. (16 more authors) (2018) (203.3) Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in cancer clinical trials: the EPiC study. In: Quality of Life Research. 25th Annual Conference of the International Society for Quality of Life Research, 24-27 Oct 2018, Dublin. Springer , S35-S35.